Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Owrang Eilami"'
Autor:
Marzieh Jamalidoust, Owrang Eilami, Zahra Ashkan, Mazyar Ziyaeyan, Nasrin Aliabadi, Mohammad Habibi
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-8 (2023)
Abstract Background/Aims The aim of this study was to determine the rate of natural and breakthrough infection and related symptoms of Covid-19 amongst Iranian healthcare workers (HCWs) who were vaccinated by different non-mRNA-based vaccines at peak
Externí odkaz:
https://doaj.org/article/15d1108a15c3457498621add60931c0c
Autor:
Ali A Asadi-Pooya, Meshkat Nemati, Mina Shahisavandi, Hamid Nemati, Afrooz Karimi, Anahita Jafari, Sara Nasiri, Seyyed Saeed Mohammadi, Zahra Rahimian, Hossein Bayat, Ali Akbari, Amir Emami, Owrang Eilami
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0296680 (2024)
ObjectiveThe current study aimed to identify the association between COVID-19 vaccination and prolonged post-COVID symptoms (long-COVID) in adults who reported suffering from this condition.MethodsThis was a retrospective follow-up study of adults wi
Externí odkaz:
https://doaj.org/article/633cf5fa856f48918b8447afcd469973
Autor:
Seyed Reza Mousavi, Majidreza Farrokhi, Navid Kalani, Tina Mosalanezhad, Fatemeh Karimi, Owrang Eilami, Ali Kazeminezhad
Publikováno v:
Iranian Journal of Neurosurgery, Vol 9 (2023)
Background and Aim: SARS-COV-2 can present with pulmonary, renal, gastrointestinal, hematological, and neurological manifestations. Neurological manifestations may occur after or before COVID-19 symptoms and signs. Spine and spinal cord complications
Externí odkaz:
https://doaj.org/article/64e3c860ffa54913b7ffdcd51e2ff88d
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background The current literature is scarce as to the outcomes of COVID-19 infection in non-Hodgkin's lymphoma patients and whether immunosuppressive or chemotherapeutic agents can cause worsening of the patients’ condition during COVID-19
Externí odkaz:
https://doaj.org/article/21641fe25ca54ba2a5c805dd2e2645d1
Autor:
Mobina Fathi, Kimia Vakili, Fatemeh Sayehmiri, Ashraf Mohamadkhani, Mohammadreza Hajiesmaeili, Mostafa Rezaei-Tavirani, Owrang Eilami
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246190 (2021)
Background and objectivesWith the increase in the number of COVID-19 infections, the global health apparatus is facing insufficient resources. The main objective of the current study is to provide additional data regarding the clinical characteristic
Externí odkaz:
https://doaj.org/article/909878e06ab64c0e8d27dc483f70b65d
Autor:
Alireza Mirahmadizadeh, Alireza Heiran, Kamran Bagheri Lankarani, Mohammadreza Serati, Mohammad Habibi, Owrang Eilami, Fatemeh Heiran, Mohsen Moghadami
BackgroundThere are some concerns about the effectiveness of the inactivated and vector-based vaccines against SARS-CoV-2 in the real-world settings with the emergence of new mutations, especially variants of concern. Data derived from administrative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5aa5f7488bf234b3e64b63fd51829a4
https://doi.org/10.1101/2022.01.18.22269330
https://doi.org/10.1101/2022.01.18.22269330
Autor:
Alireza Mirahmadizadeh, Alireza Heiran, Kamran Bagheri Lankarani, Mohammadreza Serati, Mohammad Habibi, Owrang Eilami, Fatemeh Heiran, Mohsen Moghadami
Publikováno v:
Open forum infectious diseases. 9(6)
Background There are some concerns about the effectiveness of the inactivated and vector-based vaccines against severe acute respiratory syndrome coronavirus 2 in real-world settings with the emergence of new mutations, especially variants of concern
Autor:
Alireza Mirahmadizadeh, Ali Semati, Alireza Heiran, Mostafa Ebrahimi, Abdolrasool Hemmati, Mohammadreza Karimi, Souzan Basir, Marjan Zare, Antonio Charlys da Costa, Mohammad Zeinali, Maryam Sargolzaee, Owrang Eilami
Publikováno v:
Respirology (Carlton, Vic.). 27(9)
Ivermectin is a known anti-parasitic agent that has been investigated as an antiviral agent against coronavirus disease 2019 (COVID-19). This study aimed to evaluate the efficacy of ivermectin in mild COVID-19 patients.In this multi-arm randomized cl
Autor:
Masoumeh Nazeri, Kamiar Zomorodian, Neil J. Spratt, Mehrdad Estakhr, Peyman Petramfar, Nahid Ashjazadeh, Maryam Poursadeghfard, Vahid Reza Ostovan, Mohsen Moghaddami, Bijan Khademi, Owrang Eilami, Carlos Garcia Esperson, Zahra Bahrami, Amir Rudgari, Afshin Borhani-Haghighi, Hanieh Bazrafshan, Mahtab Rostamihosseinkhani, Fatemeh KianiAra, Zahra Ghotbi, Christopher R Levi, Sadegh Izadi, Etrat Hooshmandi, Anahid Safari, Mahsa Kohandel-Shirazi, Abbas Rahimi-Jaberi, Mohammad Saied Salehi, Razieh Shafaei, Masoud Janipour, Mohammad Javad Ashraf, Pariya Kouhi, Behzad Khademi, Nima Fadakar, Marzieh Basir
Background Aneurysm formation of internal carotid arteries (ICA) in patients with mucormycosis is a scarce phenomenon. However, the prevalence of rhino-cerebral mucormycosis has been reported to increase after the coronavirus disease 2019 (COVID-19)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60459ea37de458fb03825053e1249e7e
https://doi.org/10.21203/rs.3.rs-853134/v1
https://doi.org/10.21203/rs.3.rs-853134/v1
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-5 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background The current literature is scarce as to the outcomes of COVID-19 infection in non-Hodgkin's lymphoma patients and whether immunosuppressive or chemotherapeutic agents can cause worsening of the patients’ condition during COVID-19 infectio